Inogen Inc  

(Public, NASDAQ:INGN)   Watch this stock  
Find more results for INGN
21.38
+0.61 (2.94%)
Oct 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 20.33 - 21.57
52 week 13.12 - 24.50
Open 20.85
Vol / Avg. 50,825.00/73,534.00
Mkt cap 378.85M
P/E     -
Div/yield     -
EPS -3.39
Shares 18.24M
Beta     -
Inst. own 84%
Aug 12, 2014
Q2 2014 Inogen Inc Earnings Call
Aug 12, 2014
Q2 2014 Inogen Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 7.52% 33.71%
Operating margin 13.04% 5.92%
EBITD margin - 17.24%
Return on average assets 6.53% 39.14%
Return on average equity 8.38% -
Employees 354 -
CDP Score - -

Address

326 Bollay Drive
GOLETA, CA 93117
United States - Map
+1-805-5620500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Inogen, Inc. (Inogen) is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One systems for the patients who require long-term oxygen therapy. The Company�s products include Inogen One G3 and Inogen One G2. The Inogen One G3 and Inogen One G2, weighs at approximately 4.8 and 7.0 pounds, respectively, are amongst the most lightweight portable oxygen concentrators. It markets its product offerings, the Inogen One G3 and the Inogen One G2, as single solutions for oxygen therapy. One G2 is effective for nocturnal use. Its Inogen One G2 and the Inogen One G3 are sub-5 and sub-10 pound portable oxygen.

Officers and directors

Heath Lukatch Ph.D. Independent Chairman of the Board
Age: 46
Bio & Compensation  - Reuters
Raymond O. Huggenberger President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Alison Bauerlein Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary
Age: 32
Bio & Compensation  - Reuters
Scott Wilkinson Executive Vice President - Sales and Marketing
Age: 49
Bio & Compensation  - Reuters
Matthew Scribner Executive Vice President - Operations
Age: 46
Bio & Compensation  - Reuters
Brenton Taylor Executive Vice President - Engineering
Age: 32
Bio & Compensation  - Reuters
Byron Myers Vice President - Marketing
Age: 34
Bio & Compensation  - Reuters
Heather D. Rider Director
Age: 55
Bio & Compensation  - Reuters
Benjamin M. Anderson-Ray Independent Director
Age: 58
Bio & Compensation  - Reuters
Charles E. Larsen Independent Director
Age: 62
Bio & Compensation  - Reuters